Berkshire Capital Holdings Inc. lifted its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 879,200.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 87,930 shares of the company’s stock after purchasing an additional 87,920 shares during the period. Astera Labs makes up about 4.8% of Berkshire Capital Holdings Inc.’s holdings, making the stock its 8th biggest position. Berkshire Capital Holdings Inc.’s holdings in Astera Labs were worth $14,628,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Vanguard Group Inc. raised its position in shares of Astera Labs by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock worth $2,300,344,000 after purchasing an additional 84,365 shares during the period. State Street Corp raised its position in Astera Labs by 9.1% during the third quarter. State Street Corp now owns 2,339,451 shares of the company’s stock valued at $458,065,000 after buying an additional 195,992 shares during the period. Amundi raised its position in Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after buying an additional 1,319,643 shares during the period. Value Aligned Research Advisors LLC raised its position in Astera Labs by 16.7% during the third quarter. Value Aligned Research Advisors LLC now owns 1,378,351 shares of the company’s stock valued at $269,881,000 after buying an additional 197,320 shares during the period. Finally, BNP Paribas Financial Markets raised its position in Astera Labs by 577.3% during the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after buying an additional 960,899 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on the company. Royal Bank Of Canada upped their price target on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, May 6th. TD Cowen upped their price target on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research report on Wednesday, May 6th. Evercore reiterated an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a research note on Tuesday. Loop Capital initiated coverage on shares of Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 price objective on the stock. Finally, Jefferies Financial Group reissued a “buy” rating and set a $270.00 target price on shares of Astera Labs in a research note on Wednesday, May 6th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and an average target price of $233.75.
Key Stories Impacting Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Evercore ISI raised its price target on Astera Labs to $297 from $215 and kept an Outperform rating after updated AI channel checks, reinforcing the market’s view that ALAB is benefiting from strong AI infrastructure demand. Article Title
- Positive Sentiment: Multiple reports point to momentum from the AI inference boom, with traders and investors buying into the stock after bullish coverage, elevated call activity, and a “golden cross” technical breakout that can attract trend-following buyers. Article Title
- Positive Sentiment: Recent commentary highlighted Astera Labs as a beneficiary of rising AI infrastructure spending, supporting the stock’s move higher and helping it reach fresh highs. Article Title
- Neutral Sentiment: Executives including the CEO, COO, and general counsel disclosed large share sales, but several transactions were tied to pre-arranged 10b5-1 plans or tax withholding on equity awards, which makes the selling less conclusive as a bearish signal. Article Title
Insiders Place Their Bets
In other Astera Labs news, CEO Jitendra Mohan sold 325,693 shares of the company’s stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $172.14, for a total value of $56,064,793.02. Following the transaction, the chief executive officer directly owned 4,079,322 shares of the company’s stock, valued at $702,214,489.08. This represents a 7.39% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 280,000 shares of the company’s stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $249.19, for a total value of $69,773,200.00. Following the sale, the chief operating officer owned 615,000 shares of the company’s stock, valued at approximately $153,251,850. This trade represents a 31.28% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,915,461 shares of company stock valued at $358,508,976 in the last three months. Insiders own 12.50% of the company’s stock.
Astera Labs Price Performance
Shares of ALAB stock opened at $306.88 on Friday. Astera Labs, Inc. has a fifty-two week low of $84.78 and a fifty-two week high of $315.81. The stock’s 50-day moving average is $170.39 and its two-hundred day moving average is $159.79. The firm has a market cap of $52.60 billion, a P/E ratio of 207.35, a PEG ratio of 3.94 and a beta of 3.35.
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same period in the prior year, the firm posted $0.33 EPS. The business’s revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, research analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current year.
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
- Five stocks we like better than Astera Labs
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
